US Patent Issued to Sloan-Kettering Institute for Cancer Research, Tri-Institutional Therapeutics Discovery Institute on Nov. 25 for "PI3K inhibitors and uses thereof" (American, Japanese, Israeli Inventors)

ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,478,616, issued on Nov. 25, was assigned to Sloan-Kettering Institute for Cancer Research (New York) and Tri-Institutional Therapeutics Discovery Institute Inc. (New York).

"PI3K inhibitors and uses thereof" was invented by Makoto Fushimi (Harrison, N.Y.), Maurizio Scaltriti (New York), Daniel Alan Heller (New York), Carles Monterrubio Martinez (Boston), Amaia Arruabarrena Aristorena (New York), Peter T. Meinke (Scotch Plains, N.J.), Michael Andrew Foley (New York), Yasutomi Asano (Chigasaki, Japan), Kazuyoshi Aso (Yokohama, Japan), Hiroki Takahagi (Yokohama, Japan), Yosef Shamay (Zichron Yaakov, Israel), Jose Manuel Baselga Torres (New York), Yusuke Sasaki (Yokohamashi, Japan) and Ma...